Skip to main content

Aberdeen Group plc

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1716774 EDINBURGH, X0

Position in LGND

as of Mar 31, 2026 · filed Apr 29, 2026
Position Value
$17,977,284
-$4,580,468 QoQ
Shares Held
90,044
-24.5% QoQ
Ownership
0.449%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Aberdeen Group plc holds $1,803,580,461 across 84 Biotechnology names. LGND ranks #35 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $17,977,284 90,044
2025-12-31 $22,557,752 119,309
2025-09-30 $33,611,960 189,748
2025-06-30 $26,058,866 229,230
2025-03-31 $22,735,578 216,241
2024-12-31 $18,939,833 176,760
2024-09-30 $24,949,333 249,269
2024-06-30 $22,762,248 270,143
2024-03-31 $20,581,742 281,556
2023-12-31 $20,741,652 290,418
2023-09-30 $19,182,128 320,129
2023-06-30 $28,032,479 388,800
2023-03-31 $20,722,366 281,707
2022-12-31 $20,639,796 308,979
2022-09-30 $23,762,640 442,359
2022-06-30 $23,854,226 428,585
2022-03-31 $23,508,734 335,003
2021-12-31 $34,926,352 362,469
2021-09-30 $31,128,575 358,162
2021-06-30 $33,208,829 405,776
2021-03-31 $16,593,744 174,482
2020-12-31 $22,897,746 369,081
2020-09-30 $11,713,833 196,992